REGN – regeneron pharmaceuticals, inc. (US:NASDAQ)
Stock Stats
News
BioFuture™ 2024 Wraps Up: Hundreds of High-Profile Attendees Joined Record Numbers of Investors and Media [Yahoo! Finance]
Vyriad signs 'huge' deal with Novartis to develop new cancer treatments [Yahoo! Finance]
Here's Why Regeneron Pharmaceuticals (REGN) Declined in Q3 [Yahoo! Finance]
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) was upgraded by analysts at Wolfe Research to a "strong-buy" rating.
Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is now covered by analysts at Wolfe Research. They set an "outperform" rating and a $1,150.00 price target on the stock.
Form 4 REGENERON PHARMACEUTICAL For: Nov 08 Filed by: MURPHY ANDREW J
Form 4 REGENERON PHARMACEUTICAL For: Nov 01 Filed by: McCourt Marion
Form 144 REGENERON PHARMACEUTICAL Filed by: McCourt Marion
Form S-3ASR REGENERON PHARMACEUTICAL
Form 10-Q REGENERON PHARMACEUTICAL For: Sep 30
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.